| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 15.54 mm | 15.54 mm | 15.54 mm | 15.54 mm | 15.54 mm | 15.54 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.41 mm | 1.92 mm | 574.67 k | 1.37 mm |
| Cash used (since last report) | n/a | n/a | 7.16 mm | 9.74 mm | 2.91 mm | 6.96 mm |
| Cash remaining | n/a | n/a | 8.38 mm | 5.80 mm | 12.63 mm | 8.58 mm |
| Runway (months of cash) | n/a | n/a | 5.9 | 3.0 | 22.0 | 6.2 |
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 8 |
| Closed positions | 12 |
| Increased positions | 17 |
| Reduced positions | 15 |
| 13F shares | Current |
|---|---|
| Total value | 103.00 bn |
| Total shares | 28.18 mm |
| Total puts | 100.00 |
| Total calls | 1.30 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| KCK | 5.55 mm | $38.66 mm |
| Accelmed Partners II | 4.43 mm | $6.65 mm |
| Orbimed Advisors | 3.41 mm | $23.74 bn |
| MS Morgan Stanley | 2.49 mm | $17.39 bn |
| Soleus Private Equity Fund I | 2.43 mm | $16.86 mm |
| Soleus Capital Management | 2.43 mm | $16.96 bn |
| Kent Lake PR | 1.25 mm | $8.71 bn |
| Vanguard | 995.20 k | $6.94 bn |
| MDT Medtronic | 965.94 k | $9.74 mm |
| Millennium Management | 739.99 k | $5.16 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Feb 25 | Martha Morrell | Common Stock | Sell | Dispose S | No | Yes | 13.7213 | 78,334 | 1.07 mm | 81,993 |
| 20 Feb 25 | Martha Morrell | Common Stock | Payment of exercise | Dispose F | No | No | 14.23 | 3,405 | 48.45 k | 43,670 |
| 20 Feb 25 | KCK | Common Stock | Sell | Dispose S | No | No | 9.4 | 5,270,845 | 49.55 mm | 0 |
| 30 Jan 25 | Martha Morrell | Common Stock | Sell | Dispose S | No | Yes | 15 | 200 | 3.00 k | 86,762 |
| 29 Jan 25 | Martha Morrell | Common Stock | Sell | Dispose S | No | Yes | 15 | 100 | 1.50 k | 86,962 |
| 24 Jan 25 | Martha Morrell | Common Stock | Sell | Dispose S | No | Yes | 15.01 | 3,200 | 48.03 k | 87,062 |
| 22 Jan 25 | Martha Morrell | Common Stock | Payment of exercise | Dispose F | No | No | 14.04 | 265 | 3.72 k | 47,075 |
| 3 Dec 24 | Martha Morrell | Common Stock | Payment of exercise | Dispose F | No | No | 11.93 | 1,413 | 16.86 k | 47,340 |
| 20 Nov 24 | Martha Morrell | Common Stock | Payment of exercise | Dispose F | No | No | 9.19 | 3,045 | 27.98 k | 48,753 |
| 22 Oct 24 | Martha Morrell | Common Stock | Payment of exercise | Dispose F | No | No | 6 | 237 | 1.42 k | 51,798 |
